WZMÁ
MPRZDARWAR
CRPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
MeiraGTxmeiragtx.com DASOON |
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company developing potentially curative treatm | London/New York, New York | 201-1000 | — |
Aavantgardeaavantgarde.bio |
— | — | — | |
REGENXBIOregenxbio.com SV  ODAK |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
uniQureuniqure.com  PL DH MW |
uniQure is a gene therapy company with a modular, validated technology platform that advances a pipeline of proprietary and partne | Amsterdam, 1105BP | 201-1000 | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Crispagencrispagen.com |
— | — | — | |
Editas Medicineeditasmedicine.com LB  AKJX |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Beam Therapeuticsbeamtx.com  MP SKSG |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Logicbiologicbio.com |
— | — | — | |
Homologymedicinehomologymedicine.com |
— | — | — | |
Genetherapysciencesgenetherapysciences.com |
— | — | — | |
Aveyxaveyx.com |
— | — | — | |
Ceregeneceregene.com |
Ceregene is a biotechnology company developing gene therapies that deliver nervous system growth factors to treat neurodegenerativ | San Diego, California | 51-200 | — |
Encoded Therapeuticsencoded.com  JS ST EM |
Encoded Therapeutics is a biotechnology company developing one-time, disease-modifying gene therapies for pediatric central nervou | South San Francisco, California | 51-200 | — |
Alcyonetxalcyonetx.com DBMS  PC |
Alcyone Therapeutics is a biotechnology company developing next-generation intra-CSF genetic therapies for patients with complicat | Lowell, Massachusetts | 1-10 | — |
AAVantgardeaavantgarde.com |
AAVantgarde is a clinical-stage biotechnology company based in Waltham, Massachusetts, advancing gene therapy treatments for patie | Waltham, Massachusetts | 51-200 | — |
Adverum Biotechnologiesadverumbio.com |
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biopharmaceutical company developing gene therapy treatments for highly | Redwood City, California | 201-1000 | — |
Atsena Therapeuticsatsenatx.com |
Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause blind | Millburn, New Jersey | 11-50 | — |
AviadoBioaviadobio.com |
AviadoBio is a biotechnology company developing gene therapy medicines for frontotemporal dementia (FTD) and amyotrophic lateral s | London, England | 51-200 | — |
Rocket Pharmaceuticalsrocketpharma.com |
Rocket Pharmaceuticals (NASDAQ: RCKT) is a fully-integrated, clinical-stage biotechnology company developing RP-A501, a gene thera | Cranbury, New Jersey | 201-1000 | — |
Kriya Therapeuticskriyatherapeutics.com |
Kriya Therapeutics is a biopharmaceutical company developing gene therapies for ophthalmology, neurology, and metabolic diseases, | Palo Alto, California | 51-200 | — |
Lexeo Therapeuticslexeotx.com |
Lexeo Therapeutics is a clinical-stage genetic medicines company based in New York City that develops gene therapy candidates for | New York, New York | 51-200 | — |
Aperturagtxaperturagtx.com |
Apertura is a biotechnology company developing next-generation AAV gene therapies for treating debilitating diseases with limited | New York, New York | 1-10 | — |
Coave Therapeuticscoavetx.com |
Coave Therapeutics is a clinical-stage biotechnology company developing targeted gene therapies for rare ocular and CNS diseases u | Paris, île-de-france | 51-200 | — |
Dyno Therapeuticsdynotx.com |
Dyno is a biotechnology company building high-performance genetic technologies for gene delivery, with a stated mission of unlocki | Watertown, Massachusetts | 51-200 | — |
Kriyatxkriyatx.com |
Kriya is a biopharmaceutical company developing gene therapies to treat chronic diseases affecting millions of people, with operat | Morrisville, North Carolina | 201-1000 | — |
AskBioaskbio.com |
AskBio is a gene therapy company and wholly owned, independently operated subsidiary of Bayer AG, developing investigational AAV g | Research Triangle Park, North Carolina | 201-1000 | — |
Homology Medicineshomologymedicines.com |
Homology Medicines is a genetic medicines company based in Waltham, Massachusetts, dedicated to treating patients with rare geneti | Waltham, Massachusetts | 51-200 | — |
CRISPR Therapeuticscrisprtx.com |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Unique Mindsuniqueminds.com |
Unique Minds is a software development company founded in 2024 in Redmond, Washington, that integrates artificial intelligence to | Redmond, Washington | 1-10 | — |
| Run live for more | ||||
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company developing potentially curative treatments for both rare and prevalent diseases, with four late-stage clinical programs using local delivery of small doses for inherited and more common diseases in the eye, Parkinson's disease, and radiation-induced xerostomia.
Companies like MeiraGTx include Aavantgarde, REGENXBIO, uniQure, Pregenen, Crispagen. See the full list of 24 competitors and alternatives above.
MeiraGTx has approximately 201-1000 employees and is in the Biotechnology industry.
MeiraGTx is headquartered in London/New York, New York.
MeiraGTx operates in the Biotechnology industry.
Key decision-makers and buying contacts at MeiraGTx are listed above, including leaders across executive, finance, sales and operations.